Satellos Bioscience
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$11,322,437 over the previous period. Total operating expenses were $8,378,619.
Profit Margin
| 2019 | 0 | -1.93M | |
|---|---|---|---|
| 2020 | 0 | -1.57M | |
| 2021 | 0 | -15.50M | |
| 2022 | 0 | -11.32M |
MSCL.V Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 336.94K | 119.91K | 48.16K | 3.06K |
Gross profit | -336.94K | -119.91K | -48.16K | -3.06K |
Operating exp. | ||||
Research and development | 2.58M | 1.88M | 892.78K | 917.47K |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 8.37M | 4.54M | 1.42M | 2.20M |
Operating income | -8.40M | -4.73M | -1.54M | -2.20M |
Other income (expenses), net | -2.95M | -9.86M | 349.79K | 2.64K |
Income before tax | -11.31M | -15.50M | -1.57M | -2.20M |
Income tax expense | 5.61K | 900.89K | -51.95K | -264.79K |
Net income | -11.32M | -15.50M | -1.57M | -1.93M |
Earnings per share | ||||
Basic EPS | -0.32 | -0.64 | -0.04 | -0.32 |
Diluted EPS | -0.32 | -0.64 | -0.04 | -0.32 |